MindBio Therapeutics Advances Voice-Based AI Technology for Real-Time Impairment Detection

MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) is advancing an AI-powered voice analysis platform designed to rapidly detect drug and alcohol impairment from short speech samples. The technology offers a non-invasive alternative to traditional breath, saliva, urine, and laboratory-based testing methods. Trained on more than 50 million data points and analyzing over 140 acoustic markers, the platform aims to deliver real-time impairment assessments through Edge AI kiosks. Initial field testing is planned for 2026, with an initial commercial focus on South American mining operations, where large-scale workforce screening presents significant safety and logistical challenges.

The global alcohol and drug testing devices market is projected to grow from approximately $2.5 billion in 2025 to $4.2 billion by 2033. MindBio sees opportunities to expand its platform into aviation, construction, transportation, law enforcement, call centers, and healthcare. The company is leveraging its proprietary research to address the increasing demand for faster, scalable workplace impairment detection. According to the company, the AI prediction model uses over 50 million data points to predict alcohol intoxication with remarkable accuracy, just by using the human voice.

MindBio is developing an enterprise platform including Edge-AI kiosks integrating bespoke hardware and software for the detection of drug and alcohol intoxication using the human voice and AI in a range of enterprise environments. The technology aims to address the limitations of current testing methods, which often require specialized equipment, trained personnel, and can be invasive or time-consuming. Voice-based detection offers a quick, non-invasive alternative that can be deployed in various settings.

The company's focus on South American mining operations is strategic, given the large workforce and stringent safety regulations in the mining industry. Workplace impairment is a major safety concern in mining, where operating heavy machinery and performing complex tasks under the influence can lead to accidents and fatalities. By providing real-time impairment detection, MindBio's technology could help reduce workplace accidents and improve safety compliance.

Beyond mining, the platform has potential applications in aviation, construction, transportation, and law enforcement, where impairment testing is critical for safety. The technology could also be used in call centers and healthcare settings to ensure employee fitness for duty. As the market for alcohol and drug testing devices expands, MindBio is positioning itself to capture a share of this growing market with its innovative voice-based solution.

For more information about MindBio Therapeutics, visit the company's newsroom at https://ibn.fm/MBQIF. To view the full article, visit https://ibn.fm/Gw5Fa.